108 related articles for article (PubMed ID: 17444381)
21. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
Rode H; de Wet PM; Davies MR; Cywes S
Prog Pediatr Surg; 1981; 14():189-208. PubMed ID: 7221007
[TBL] [Abstract][Full Text] [Related]
22. Comparison between topical honey and mafenide acetate in treatment of auricular burn.
Hashemi B; Bayat A; Kazemei T; Azarpira N
Am J Otolaryngol; 2011; 32(1):28-31. PubMed ID: 20015812
[TBL] [Abstract][Full Text] [Related]
23. [Bacteriological effects and immunologic function changes in the burn area treated with "moist ointment"].
Chen B; Bai G; Tang CW
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1994 Jan; 10(1):19-22. PubMed ID: 8087683
[No Abstract] [Full Text] [Related]
24. Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds.
Björn C; Noppa L; Näslund Salomonsson E; Johansson AL; Nilsson E; Mahlapuu M; Håkansson J
Int J Antimicrob Agents; 2015 May; 45(5):519-24. PubMed ID: 25649371
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a bi-layer wound dressing for burn care. II. In vitro and in vivo bactericidal properties.
Martineau L; Shek PN
Burns; 2006 Mar; 32(2):172-9. PubMed ID: 16455202
[TBL] [Abstract][Full Text] [Related]
26. The Effective Duration of Antimicrobial Activity of Mafenide Acetate After Reconstitution.
Afshari A; Nguyen L; Kahn SA; Montgomery AC; Shinha T; Stratton C; Summitt B
J Burn Care Res; 2018 Aug; 39(5):736-738. PubMed ID: 29931082
[TBL] [Abstract][Full Text] [Related]
27. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
[TBL] [Abstract][Full Text] [Related]
28. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of wound healing activities of kefir products.
Huseini HF; Rahimzadeh G; Fazeli MR; Mehrazma M; Salehi M
Burns; 2012 Aug; 38(5):719-23. PubMed ID: 22237053
[TBL] [Abstract][Full Text] [Related]
30. Formation of Pseudomonas aeruginosa Biofilms in Full-thickness Scald Burn Wounds in Rats.
Brandenburg KS; Weaver AJ; Karna SLR; You T; Chen P; Stryk SV; Qian L; Pineda U; Abercrombie JJ; Leung KP
Sci Rep; 2019 Sep; 9(1):13627. PubMed ID: 31541159
[TBL] [Abstract][Full Text] [Related]
31. In vitro efficacy of various topical antimicrobial agents in different time periods from contamination to application against 6 multidrug-resistant bacterial strains isolated from burn patients.
Hajská M; Slobodníková L; Hupková H; Koller J
Burns; 2014 Jun; 40(4):713-8. PubMed ID: 24091332
[TBL] [Abstract][Full Text] [Related]
32. Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated wounds with devitalized tissue.
Mendelson JA
Prehosp Disaster Med; 2001; 16(3):172-4. PubMed ID: 11875802
[TBL] [Abstract][Full Text] [Related]
33. Mafenide acetate concentrations and bacteriostasis in experimental burn wounds treated with a three-layered laminated mafenide-saline dressing.
Falcone PA; Harrison HN; Sowemimo GO; Reading GP
Ann Plast Surg; 1980 Oct; 5(4):266-9. PubMed ID: 6985504
[TBL] [Abstract][Full Text] [Related]
34. Development of Pseudomonas aeruginosa Biofilms in Partial-Thickness Burn Wounds Using a Sprague-Dawley Rat Model.
Brandenburg KS; Weaver AJ; Qian L; You T; Chen P; Karna SLR; Fourcaudot AB; Sebastian EA; Abercrombie JJ; Pineda U; Hong J; Wienandt NA; Leung KP
J Burn Care Res; 2019 Jan; 40(1):44-57. PubMed ID: 30137429
[TBL] [Abstract][Full Text] [Related]
35. Shiunko promotes epithelization of wounded skin.
Huang KF; Hsu YC; Lin CN; Tzeng JI; Chen YW; Wang JJ
Am J Chin Med; 2004; 32(3):389-96. PubMed ID: 15344422
[TBL] [Abstract][Full Text] [Related]
36. Rapid degradation and non-selectivity of Dakin's solution prevents effectiveness in contaminated musculoskeletal wound models.
Mangum LC; Franklin NA; Garcia GR; Akers KS; Wenke JC
Injury; 2018 Oct; 49(10):1763-1773. PubMed ID: 30104015
[TBL] [Abstract][Full Text] [Related]
37. Using mafenide acetate in acute and chronic wounds.
Barillo DJ
Ostomy Wound Manage; 2002 Sep; Suppl():5-10. PubMed ID: 12298221
[No Abstract] [Full Text] [Related]
38. The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity.
Zhou H; Dou J; Wang J; Chen L; Wang H; Zhou W; Li Y; Zhou C
Peptides; 2011 Jun; 32(6):1131-8. PubMed ID: 21515321
[TBL] [Abstract][Full Text] [Related]
39. Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing.
Said SS; El-Halfawy OM; El-Gowelli HM; Aloufy AK; Boraei NA; El-Khordagui LK
Eur J Pharm Biopharm; 2012 Jan; 80(1):85-94. PubMed ID: 21924354
[TBL] [Abstract][Full Text] [Related]
40. Allergic contact dermatitis to mafenide acetate: a case series and review of the literature.
Firoz EF; Firoz BF; Williams JF; Henning JS
J Drugs Dermatol; 2007 Aug; 6(8):825-8. PubMed ID: 17763614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
